Prenetics Global Limited Class A (PRE)

$4.94

+0.64

(+14.88%)

Market is closed - opens 7 PM, 07 Oct 2024

Performance

  • $4.29
    $5.18
    $4.94
    downward going graph

    13.12%

    Downside

    Day's Volatility :17.14%

    Upside

    4.63%

    downward going graph
  • $0.40
    $7.84
    $4.94
    downward going graph

    91.9%

    Downside

    52 Weeks Volatility :94.9%

    Upside

    36.97%

    downward going graph

Returns

PeriodPrenetics Global Limited Class ASector (Health Care)Index (Russel 2000)
3 Months
-28.09%
4.9%
0.0%
6 Months
18.46%
5.8%
0.0%
1 Year
-34.85%
17.8%
0.0%
3 Years
-96.25%
20.1%
-20.6%

Highlights

Market Capitalization
50.6M
Book Value
$16.33
Earnings Per Share (EPS)
-4.28
PEG Ratio
0.0
Wall Street Target Price
9.0
Profit Margin
-262.11%
Operating Margin TTM
-142.81%
Return On Assets TTM
-10.9%
Return On Equity TTM
-23.71%
Revenue TTM
23.2M
Revenue Per Share TTM
1.99
Quarterly Revenue Growth YOY
-63.800000000000004%
Gross Profit TTM
131.6M
EBITDA
-41.6M
Diluted Eps TTM
-4.28
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-3.32
EPS Estimate Next Year
-0.56
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
-0.93

Analyst Recommendation

Buy
    80%Buy
    20%Hold
    0
    0%Sell
Based on 5 Wall street analysts offering stock ratings for Prenetics Global Limited Class A(by analysts ranked 0 to 5 stars)
Based on 5 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
4
4
5
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 82.19%

Current $4.94
Target $9.00

Technicals Summary

Sell

Neutral

Buy

Prenetics Global Limited Class A is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Prenetics Global Limited Class A
Prenetics Global Limited Class A
-4.87%
18.46%
-34.85%
-96.25%
-96.25%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
3.06%
-6.93%
12.31%
-21.35%
77.73%
Agilent Technologies Inc.
Agilent Technologies Inc.
4.47%
0.3%
30.99%
-5.54%
92.48%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
-0.98%
3.7%
20.66%
5.08%
107.82%
Danaher Corp.
Danaher Corp.
2.19%
10.74%
24.74%
-9.68%
93.67%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
-8.36%
-5.82%
14.95%
-5.0%
52.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Prenetics Global Limited Class A
Prenetics Global Limited Class A
1.03
NA
0.0
-3.32
-0.24
-0.11
NA
16.33
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
47.87
47.87
5.09
10.59
0.63
0.23
NA
19.16
Agilent Technologies Inc.
Agilent Technologies Inc.
30.05
30.05
3.16
5.24
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
38.03
38.03
2.28
21.73
0.14
0.05
0.0
124.17
Danaher Corp.
Danaher Corp.
50.26
50.26
2.71
7.59
0.08
0.04
0.0
68.92
Iqvia Holdings Inc.
Iqvia Holdings Inc.
29.57
29.57
1.15
11.2
0.23
0.05
NA
36.83
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Prenetics Global Limited Class A
Prenetics Global Limited Class A
Buy
$50.6M
-96.25%
1.03
-262.11%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Buy
$40.0B
77.73%
47.87
22.34%
Agilent Technologies Inc.
Agilent Technologies Inc.
Buy
$42.1B
92.48%
30.05
21.75%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Buy
$234.1B
107.82%
38.03
14.69%
Danaher Corp.
Danaher Corp.
Buy
$197.8B
93.67%
50.26
17.83%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
Buy
$41.5B
52.93%
29.57
9.39%

Insights on Prenetics Global Limited Class A

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 4.86M → 6.41M (in $), with an average increase of 12.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -19.04M → -8.56M (in $), with an average increase of 122.3% per quarter

  • Vs A

    In the last 1 year, Agilent Technologies Inc. has given 31.0% return, outperforming this stock by 65.8%

Institutional Holdings

  • Prudential Corp PLC

    3.95%
  • Aspex Management (HK) Ltd

    2.83%
  • Nomura Holdings Inc

    2.64%
  • UBS Group AG

    0.33%

Company Information

Organization
Prenetics Global Limited Class A
Employees
320
CEO
Mr. Sheng Wu Yeung
Industry
Healthcare

FAQs